BioMerieux Total Long-Term Assets 2017-2024 | BMXMF
BioMerieux total long-term assets from 2017 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
- BioMerieux total long-term assets for the quarter ending December 31, 2024 were $1.702B, a 3.69% decline year-over-year.
- BioMerieux total long-term assets for 2024 were $3.537B, a 7.01% increase from 2023.
- BioMerieux total long-term assets for 2023 were $3.305B, a 5.63% increase from 2022.
- BioMerieux total long-term assets for 2022 were $3.129B, a 9.77% increase from 2021.
| BioMerieux Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $3,537 |
| 2023 | $3,305 |
| 2022 | $3,129 |
| 2021 | $2,851 |
| 2020 | $2,589 |
| 2019 | $2,624 |
| 2018 | $2,473 |
| 2017 | $1,931 |
| 2016 | $2,043 |
| 2015 | $0 |
| BioMerieux Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,702 |
| 2023-12-31 | $1,675 |
| 2023-06-30 | $1,621 |
| 2022-12-31 | $1,686 |
| 2022-06-30 | $1,768 |
| 2021-12-31 | $1,402 |
| 2021-06-30 | $1,474 |
| 2020-12-31 | $1,368 |
| 2019-12-31 | $1,476 |
| 2019-06-30 | $1,522 |
| 2018-12-31 | $1,519 |
| 2018-06-30 | $1,280 |
| 2017-12-31 | $1,127 |
| 2017-06-30 | $1,158 |
| 2016-12-31 | $1,230 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.890B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $137.452B | 25.78 |
| Elevance Health (ELV) | United States | $85.620B | 11.05 |
| CVS Health (CVS) | United States | $80.443B | 10.00 |
| Cencora (COR) | United States | $56.509B | 19.66 |
| Natera (NTRA) | United States | $21.868B | 0.00 |
| DiDi Global (DIDIY) | China | $21.650B | 32.86 |
| Solventum (SOLV) | United States | $12.848B | 13.60 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.645B | 0.00 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| ICON (ICLR) | Ireland | $10.802B | 10.04 |
| Revvity (RVTY) | United States | $10.730B | 18.47 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| Doximity (DOCS) | United States | $10.051B | 46.53 |
| HealthEquity (HQY) | United States | $8.975B | 39.30 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| Medpace Holdings (MEDP) | United States | $8.797B | 23.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.802B | 13.33 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.121B | 38.15 |
| Bausch + Lomb (BLCO) | Canada | $4.065B | 23.96 |
| Sotera Health (SHC) | United States | $3.486B | 19.81 |
| Alignment Healthcare (ALHC) | United States | $3.035B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.984B | 38.80 |
| Concentras Parent (CON) | United States | $2.776B | 16.04 |
| Organon (OGN) | United States | $2.454B | 2.61 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.078B | 80.01 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.884B | 41.47 |
| PACS (PACS) | United States | $1.554B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.407B | 28.14 |
| Teladoc Health (TDOC) | United States | $1.239B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.186B | 9.02 |
| Establishment Labs Holdings (ESTA) | $1.061B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.971B | 15.16 |
| Agilon Health (AGL) | United States | $0.940B | 0.00 |
| Nutex Health (NUTX) | United States | $0.825B | 12.46 |
| AMN Healthcare Services Inc (AMN) | United States | $0.783B | 7.33 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.620B | 4.18 |
| LifeMD (LFMD) | United States | $0.575B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| SBC Medicals (SBC) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.491B | 11.07 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.254B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| DocGo (DCGO) | United States | $0.151B | 24.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.094B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| ModivCare (MODV) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |